Children's health
20 Nov 2007
Impact of Diet on Allergy Risk
Over the last few decades, there has been a huge increase in the number of people suffering from allergies. A large number of studies are beginning…
Children's Health
20 Nov 2007
Nutrition in Adolescent Girls
Adolescence is the transition period between childhood and adulthood, typically between the ages of 10 and 13 years in girls. Adolescence is characterised by the…
Blood
20 Nov 2007
Nutrition for lowering cholesterol levels
Both dietary changes and drugs are used in the management of cholesterol levels. In most cases, the dietary approach is the first option, since dietary…
Children's health
16 Nov 2007
Annual Flu Shot Cuts Need for Doctors’ Visits, Hospitalization among Children
Children under the age of 5 who receive an annual flu shot have a greatly reduced risk of needing to see their doctor or be admitted to the hospital because of flu-related illness. A new study in the September issue of Pediatrics that analyses how many outpatient visits or hospitalizations…
Bone
16 Nov 2007
COSA ASM 2007 Highlights
The 34th COSA ASM offered a series of stimulating and exciting presentations from international and national experts covering the many disciplines of oncology research and clinical practice. The conference was held at the Adelaide Convention Centre on November 14-16, 2007. Some of the presentations that took place are summarised here.
Children's health
16 Nov 2007
Link between Asthma and Depressive and Anxiety Disorders
Young people with asthma are about twice as likely to suffer from depressive and anxiety disorders than are children without asthma, according to a study by a research team in Seattle. Previous research had suggested a possible link in young people between asthma and some mental health problems, such as…
Blood
16 Nov 2007
Young Cancer Patients Failing to Receive the Best Cancer Treatment
Adolescent and young adult cancer patients are experiencing a reduced survival rate because they are failing to be involved in clinical trials, a meeting of national cancer experts will hear today. The UK Teenage Cancer Trust’s visiting professor, Dr David Walker, said young people who did take part in medical…
Blood
16 Nov 2007
New Anti-cancer Drug Now Subsidised by the Government
A government committee has recently announced its addition of Velcade (bortezomib) to the Australian Pharmaceutical Benefits Scheme (PBS). Velcade is a novel drug used to treat an aggressive blood cancer called multiple myeloma. Although the treatment is worth several thousands of dollars, patients can now access the drug at heavily…
Blood
16 Nov 2007
New Hope for Patients with Myeloma as Velcade is Added to the PBS
A novel therapy for advanced and progressive stages of multiple myeloma has become available on the Australian Pharmaceutical Benefits Scheme from November 1st 2007. This is fantastic news for sufferers of this rare and debilitating haematological cancer, whom normally face a poor prognosis without treatment. Multiple myeloma (MM) is a…
